FTSE All-Share
|
5 242,46
|
-23,28
|
-0,44 %
|
Analysen zu FTSE All-Share-Werten
| 25.09.24 | Unilever Sell | UBS AG | |
| 25.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.09.24 | Diageo Sell | Goldman Sachs Group Inc. | |
| 24.09.24 | BP Buy | Jefferies & Company Inc. | |
| 24.09.24 | BP Underweight | JP Morgan Chase & Co. | |
| 24.09.24 | Shell Overweight | JP Morgan Chase & Co. | |
| 24.09.24 | Shell Buy | Jefferies & Company Inc. | |
| 23.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.09.24 | BP Overweight | Barclays Capital | |
| 23.09.24 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 20.09.24 | Unilever Overweight | JP Morgan Chase & Co. | |
| 20.09.24 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 20.09.24 | Rio Tinto Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.09.24 | Vodafone Group Buy | Goldman Sachs Group Inc. | |
| 18.09.24 | GSK Buy | Jefferies & Company Inc. | |
| 18.09.24 | BAT Buy | Deutsche Bank AG | |
| 18.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 17.09.24 | National Grid Buy | Goldman Sachs Group Inc. | |
| 17.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.09.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 16.09.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 16.09.24 | Vodafone Group Buy | Goldman Sachs Group Inc. | |
| 16.09.24 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.09.24 | AstraZeneca Sell | UBS AG | |
| 13.09.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 13.09.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 12.09.24 | BP Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.09.24 | Shell Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.09.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 10.09.24 | Glencore Buy | Deutsche Bank AG | |
| 10.09.24 | Rio Tinto Buy | Deutsche Bank AG | |
| 10.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 10.09.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 09.09.24 | GSK Buy | Deutsche Bank AG | |
| 09.09.24 | BAT Overweight | Barclays Capital | |
| 09.09.24 | AstraZeneca Sell | UBS AG | |
| 09.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 09.09.24 | Diageo Hold | Jefferies & Company Inc. | |
| 06.09.24 | Shell Overweight | JP Morgan Chase & Co. |
HOT STOCKS DER LETZTEN 3 TAGE
| Diageo | 5 |
| BP | 5 |
| National Grid | 2 |
| Unilever | 2 |
| GSK | 2 |
| AstraZeneca | 1 |
| London Stock Exchange | 1 |
| Rio Tinto | 1 |
| HSBC Holdings | 1 |
| Shell | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.